| 318 | 9 | 24 |
| 下载次数 | 被引频次 | 阅读次数 |
目的建立LC-MS-MS法测定人血浆中苯磺酸氨氯地平的浓度,并进行2个制剂间的生物等效性评价。方法采用随机交叉、自身对照试验设计,18名健康志愿受试者口服苯磺酸氨氯地平片受试制剂和参比制剂各10mg,以HPLC-MS-MS法测定服药后120h内不同时间点的血药浓度,计算主要药物动力学参数,以方差分析法对主要参数进行均数的差别检验,以双单侧t检验进行生物等效性判定。结果受试者分别口服受试制剂和参比制剂后主要动力学参数AUC0～120,AUC0～∞,tmax,Cmax,t1/2分别为(194.68±52.97)g.h.L-1、(192.74±49.56)μg.h.L-1、(209.29±51.85)μg.h.L-1、(209.45±55.38)μg.h.L-1,(7.0±1.3)h和(7.0±1.0)h、(6.23±1.86)μg.L-1和(6.27±2.41)μg.L-1、(32.7±10.0)h和(32.6±4.5)h。受试制剂对参比制剂的相对生物利用度为(101.0%±9.6%)。结论受试制剂与参比制剂为生物等效制剂。
Abstract：Objective To develop an LC-MS-MS method to determine the plasma concentration of amlodipine,and evaluate the bioequivalence between 2 formulations of amlodipine besylate tablets.Methods A cross-over,randomized study was performed in 18 healthy volunteers.Concentrations of amlodipine in the plasma were assayed by HPLC-MS-MS method after a single oral dose of 10 mg of the test or the reference tablets.The pharmacokinetic parameters were analyzed by two one-sided t tests to evaluate the bioequivalence of the 2 preparations.Results The main pharmacokinetic parameters AUC0～120,AUC0～∞,tmax,Cmax,and t1/2 of the test and reference preparations were as follows:(194.68±52.97)μg·h·L-1 and(192.74±49.56)μg·h·L-1;(209.29±51.85)μg·h·L-1 and(209.45±55.38)μg·h·L-1;(7.0±1.3)h and(7.0±1.0)h;(6.23±1.86)μg·L-1 and(6.27±2.41)μg·L-1;(32.7±10.0)h and(32.6±4.5)h.The relative bioavailability of amlodpine was(101.0%±9.6%).Conclusion The test and the reference preparations are bioequivalent.
[1]四川美康医药软件研究开发有限公司.药物临床信息参考[M].2006版.四川:四川科学技术出版社,2006:486-487.
[2]杜光,刘东,刘宇,等.国产苯磺酸氨氯地平片的生物等效性[J].中国医院药学杂志,2007,27(2):185-187.
[3]Rojanasthien N,Teekachunhatean S,Jakob K,et al.Bioequiv-alence study of generic amlodipine in healthy Thaimale volun-teers[J].Int J Clin Pharmacol Ther,2004,42(6):330-335.
[4]梁超,程晓华,张红,等.LC-MS法评价两种苯磺酸氨氯地平片的人体生物等效性[J].第二军医大学学报,2007,28(3):299-301.
[5]Bhatt J,Singh S,Subbaiah G,et al.Arapid and sensitiveliquid chromatography-tandem mass spectrometry(LC-MS-MS)meth-od for the estimation of amlodipine in human plasma[J].Bi-omed Chromatogr,2007,21(2):169-175.
[6]张琰,杨蕾,刘梅.苯磺酸氨氯地平片在健康人体的药动学及生物等效性评价[J].第四军医大学学报,2006,27(2):172-175.
[7]Nirogi RV,Kandikere VN,Mudigonda K,et al.Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma[J].Bi-omed Chromatogr,2006,20(9):833-842.
[8]Massaroti P,Moraes LAB,Marchioretto MAM,et al.Develop-ment and validation of a selective and robust LC-MS-MS method for quantifying amlodipine in human plasma[J].Anal Bioanal Chem,2005,382(4):1049-1054.
基本信息:
中图分类号:R96
引用信息:
[1]徐萍,朱运贵,张毕奎,等.LC-MS-MS法评价2种苯磺酸氨氯地平片的生物等效性[J].中南药学,2008,No.32(03):286-289.
2008-06-20
2008-06-20